Your input needed – three new optimum clinical pathways in neurology

*This consultation has now closed. A range of optimal clinical pathways for adults with neurological conditions, including epilepsy, Multiple Sclerosis (MS) and neurological autoimmune conditions, are being published. Learn more and download them here.*

Three new optimum clinical pathways are being developed for neurological conditions, namely:

• Epilepsy
• Multiple sclerosis
• Neurological autoimmune conditions

The clinical pathways were developed following a series of workshops in 2018 and 2019 with experts in these condition areas, including clinicians, patient groups and people with neurological conditions. Now, we need your input on these draft pathways.

The Neurological Alliance is facilitating consultation of these pathways due to our role as Co-Chair of the National Neuroscience Advisory Group.

The pathways should set out what good treatment, care and support involves. This includes treatment and support for people who may be experiencing the first symptoms of a neurological condition, right through to people who have lived with such conditions for a long time.

The intention is for these pathways to support the improvement of services, set out aspirations for good care, and enable good commissioning of neurological services locally and nationally.

Further condition specific pathways are also being developed.

*This consultation has now closed. A range of optimal clinical pathways for adults with neurological conditions, including epilepsy, Multiple Sclerosis (MS) and neurological autoimmune conditions, are being published. Learn more here.*